## IONQ: IonQ, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 2.1% below STRENGTH zone (3.0-6.0%); PEG 1.08 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-5.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($44.03)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. What's Going On With IonQ Stock Today?**
- Source: Benzinga | 20251210T160937 | Neutral | Relevance: 97%
-  IonQ shares are trading slightly lower after announcing a collaboration with Einride AB to optimize electric freight logistics using quantum computing. This partnership aims to enhance Einride's AI platform and cut costs by improving shipment scheduling for electric and autonomous trucks. The company also recently expanded into Europe with Slovakia's first national quantum communication network and partnered with the Centre for Commercialization of Regenerative Medicine.

**2. IONQ Stock Rating: Analyst Reaffirms Street-High Price Target amid Volatility**
- Source: TipRanks | 20251211T060937 | Bullish | Relevance: 97%
-  Rosenblatt Securities analyst John McPeake has reaffirmed his "Buy" rating and Street-high price target of $100 for IonQ (IONQ), implying 93.5% upside potential, despite recent stock volatility. McPeake's optimism stems from meetings with IonQ's leadership at the Q2B Silicon Valley Conference, highlighting the company's integrated product portfolio strategy and strategic acquisitions. IonQ's recent partnership with Einride AB also demonstrated real-world progress for quantum computing in commercial freight data.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($0.11M) |
| Sells | 1 ($4.69M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 32.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 8.3% (+18.5%)
- Morgan Stanley: 7.4% (+29.9%)
- Blackrock Inc.: 6.3% (+23.2%)
- Geode Capital Manage: 1.9% (+24.0%)
- State Street Corpora: 1.8% (+19.9%)

### Key Risks

1. High beta (2.62) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Insider selling cluster: $4.7M in recent transactions.
3. High short interest (18.9%, 2.6 days to cover): squeeze risk or crowded bearish bet.
4. Near-term weakness: 9.4% below SMA50 despite long-term uptrend.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.08 suggests fair value with growth premium. Balance sheet: strong liquidity (8.7x). Revenue growth strong at 76% YoY. Insider selling cluster ($4.7M in 90 days), potential headwind. Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $18.6B |
| Beta | 2.62 |
| 52W Range | $17.88 - $84.64 |
| Short Interest | 18.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.08 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_10 deteriorating from 7.7% to 2.1% (-5.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.9pp (needs >3.0% for momentum thesis). MRS_5 (-1.1%) diverging from MRS_10 - short-term weakness emerging. MACD histogram positive (1.17), confirming momentum. RSI neutral at 51.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.14% (CS: 62) | Neutral |
| RSI_14 | 50.8 | Neutral |
| MACD Histogram | 1.17 | Bullish |
| vs SMA20 | 1.080x | Above |
| vs SMA50 | 0.906x | Below |
| vs SMA200 | 1.226x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $52.55
- **Stop Loss:** $44.03 (16.2% risk)
- **Target:** $61.07 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 161
- **Position Value:** $8,460.55
- **Portfolio %:** 8.46%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-25 (Est: $-0.48)

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*